Yu Fang, Zou Xiang. Roles and relevance of mast cells in infection and vaccination[J]. The Journal of Biomedical Research, 2016, 30(4): 253-263. DOI: 10.7555/JBR.30.20150038
Citation:
Yu Fang, Zou Xiang. Roles and relevance of mast cells in infection and vaccination[J]. The Journal of Biomedical Research, 2016, 30(4): 253-263. DOI: 10.7555/JBR.30.20150038
Yu Fang, Zou Xiang. Roles and relevance of mast cells in infection and vaccination[J]. The Journal of Biomedical Research, 2016, 30(4): 253-263. DOI: 10.7555/JBR.30.20150038
Citation:
Yu Fang, Zou Xiang. Roles and relevance of mast cells in infection and vaccination[J]. The Journal of Biomedical Research, 2016, 30(4): 253-263. DOI: 10.7555/JBR.30.20150038
Clinical Research Center, Affliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550025, China
3.
Department of Microbiology and Immunology, Mucosal Immunobiology and Vaccine Research Center, Institute of Biomedicine, University of Gothenburg, Gothenburg 40530, Sweden
Funds:
This work was supported by Stiftelsen Clas Groschinskys Minnesfond
Konsul Berghs Stiftelse, Sweden. YF was supported by a postdoctoral start-up grant from the Affiliated Hospital of Guizhou Medical University, Guiyang, China.
In addition to their well-established role in allergy mast cells have been described as contributing to functional regulation of both innate and adaptive immune responses in host defense. Mast cells are of hematopoietic origin but typically complete their differentiation in tissues where they express immune regulatory functions by releasing diverse mediators and cytokines. Mast cells are abundant at mucosal tissues which are portals of entry for common infectious agents in addition to allergens. Here, we review the current understanding of the participation of mast cells in defense against infection. We also discuss possibilities of exploiting mast cell activation to provide adequate adjuvant activity that is needed in high-quality vaccination against infectious diseases.
Li M, Ning P, Bai R, et al. DNA Methylation Negatively Regulates Gene Expression of Key Cytokines Secreted by BMMCs Recognizing FMDV-VLPs. Int J Mol Sci, 2024, 25(19): 10849.
DOI:10.3390/ijms251910849
2.
Volpedo G, Pacheco-Fernandez T, Bhattacharya P, et al. Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development. Front Immunol, 2021, 12: 748325.
DOI:10.3389/fimmu.2021.748325
3.
Korkmaz E, Balmert SC, Sumpter TL, et al. Microarray patches enable the development of skin-targeted vaccines against COVID-19. Adv Drug Deliv Rev, 2021, 171: 164-186.
DOI:10.1016/j.addr.2021.01.022
4.
Zhu W, Dong C, Wei L, et al. Promising Adjuvants and Platforms for Influenza Vaccine Development. Pharmaceutics, 2021, 13(1): 68.
DOI:10.3390/pharmaceutics13010068
5.
Tong X, Chen S, Zheng H, et al. Increased IL-27/IL-27R expression in association with the immunopathology of murine ocular toxoplasmosis. Parasitol Res, 2018, 117(7): 2255-2263.
DOI:10.1007/s00436-018-5914-7
6.
Appel K, Munoz E, Navarrete C, et al. Immunomodulatory and Inhibitory Effect of Immulina®, and Immunloges® in the Ig-E Mediated Activation of RBL-2H3 Cells. A New Role in Allergic Inflammatory Responses. Plants (Basel), 2018, 7(1): 13.
DOI:10.3390/plants7010013
7.
Yoshino N, Takeshita R, Kawamura H, et al. Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice. Immun Inflamm Dis, 2018, 6(1): 117-127.
DOI:10.1002/iid3.204